Muwonge, Haruna
Nasimiyu, Carolyne
Bakamutumaho, Barnabas
Elyanu, Peter
Joloba, Moses L.
Situma, Silvia
Schieffelin, John
Gunn, Bronwyn
Bai, Shuangyi
Breiman, Robert F.
Ssewanyana, Isaac
Nabadda, Susan
Lutwama, Julius
Tegen, Yonas
Muruta, Allan
Kirenga, Bruce
Olaro, Charles
Aceng, Jane Ruth
Bosa, Henry Kyobe
Njenga, M. Kariuki
Funding for this research was provided by:
U.S. National Institute of Allergy and Infectious Diseases/National Institutes of Health (U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799, U01AI151799)
U.S. National Institute of Allergy and Infectious Diseases/National Institutes of Health (R01AI175698, R01AI175698)
Article History
Received: 28 March 2025
Accepted: 9 July 2025
First Online: 18 July 2025
Change Date: 10 September 2025
Change Type: Update
Change Details: The original article has been updated to add an Acknowledgement.
Declarations
:
: The study protocol was reviewed and approved by the School of Biomedical Sciences Research Ethics Committee at Makerere University (Approval #SBS-2022-243) and the Uganda National Council of Science and Technology (Approval #HS2618ES). Additional administrative approvals were obtained from the Uganda Ministry of Health and participating health facilities. Written informed consent was obtained from all participants prior to enrollment.
: Not applicable.
: The authors declare no competing interests.